DC Crawford, MD Ritchie, MJ Rieder - Pharmacogenomics, 2007 - Future Medicine Genotype–phenotype studies in pharmacogenomics promise to identify the genetic factors that
contribute substantially to variation in individual drug response. While most genetic association
studies have failed to deliver this ... Cited by 15 - Related articles - BL Direct - All 4 versions
SM Huang, R Temple - Clinical Pharmacology and Therapeutics, 2008 - fda.gov 1Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug
Administration, Silver Spring, Maryland, USA; 2Office of Medical Policy, Center for Drug Evaluation
and Research, Food and Drug ... Cited by 8 - Related articles - View as HTML - All 3 versions
B Séguin, B Hardy, PA Singer, AS Daar - Pharmacogenomics Journal- …, 2008 - pharmalot.com 1Program on Life Sciences, Ethics and Policy, McLaughlin-Rotman Centre for Global Health, University
Health Network/McLaughlin Centre for Molecular Medicine at University of Toronto, MaRS Centre, South
Tower, Toronto, Ontario, Canada; ... Cited by 5 - Related articles - View as HTML - BL Direct - All 4 versions
T Caulfield, SM Fullerton, SE Ali-Khan, L … - Genome …, 2009 - pubmedcentral.nih.gov 1 Faculty of Law and School of Public Health Research, Health Law Institute, University of Alberta,
89 Ave and 111 St., T6G 2H5, Canada. ... 2 Department of Medical History and Ethics and Department
of Genome Sciences, University of ... Cited by 4 - Related articles - All 7 versions
K Getz, L Faden - American journal of therapeutics, 2008 - journals.lww.com Evidence shows that minority patients are underrepresented in clinical trials. The development of
new drugs and treatments, however, requires that clinical research studies include representative
participants, particularly in light ... Cited by 3 - Related articles - BL Direct - All 3 versions
- ►berkeley.edu [PDF] DE Winickoff, OK Obasogie - Trends in Pharmacological Sciences, 2008 - Elsevier Numerous articles and commentaries in the health literature recently have questioned the emergence
of race as an increasingly powerful organizing principle in clinical medicine and pharmaceutical
development [1] and [2]. Yet ... Cited by 2 - Related articles - All 3 versions
- ►umn.edu [PDF] EA Weeks, G Hall - Journal of Law, Medicine and Ethics, 2009 - papers.ssrn.com I. Introduction Do terminally ill patients who have exhausted all other available,
government-approved treatment options have a constitutional right to experimental treatment that may
prolong their lives? On May 2, ... Cited by 2 - Related articles - All 13 versions
EM Phillips, AO Odunlami, VL … - Social forces; a scientific …, 2007 - pubmedcentral.nih.gov This article presents the findings of a qualitative study of multiracial individuals' understanding
of identity, race and human genetic variation. The debate regarding the correlation between race,
genetics and disease has expanded, ... Cited by 2 - Related articles - BL Direct - All 8 versions
SJ Coons - Clinical Therapeutics, 2009 - Elsevier 2.US Food and Drug Administration (FDA). FDA approves BiDil heart failure drug for black patients
[FDA Web site]. http://www.fda.gov/bbs/topics/news/2005/new01190.html (March 9, 2009) Accessed. ...
3.S Harry and T Caulfield, BiDil, ... Cited by 1 - Related articles - All 2 versions
KL Rice, I Leimer, S Kesten, DE Niewoehner - Translational Research, 2008 - Elsevier Sparse information exists about chronic obstructive pulmonary disease (COPD) outcomes among
different ethnic groups. To determine whether the effect of tiotropium on COPD exacerbation differs
between African Americans and ... Cited by 1 - Related articles - All 9 versions
